Clinicopathological and therapeutic analysis of Castleman's disease in children.
10.3760/cma.j.cn112140-20210601-00471
- VernacularTitle:儿童Castleman病临床病理和治疗分析
- Author:
Qing Lei MENG
1
;
Bai LI
2
;
Yi Ming WANG
2
;
Yu Feng LIU
2
;
Jun Tao BAO
1
;
Xiao Hui WANG
1
;
Shu Feng ZHANG
1
Author Information
1. Department of Pediatric Surgery, Henan Provincial People's Hospital, Zhengzhou 450003, China.
2. Department of Pediatric Hematology and Oncology, Children's Hospital, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- Publication Type:Journal Article
- MeSH:
Castleman Disease/therapy*;
Female;
Humans;
Male;
Neck/pathology*;
Prognosis;
Retrospective Studies;
Rituximab
- From:
Chinese Journal of Pediatrics
2022;60(3):227-231
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinical features, pathological phenotype, treatment and prognosis of Castleman's disease in children. Methods: Clinical data of 15 children diagnosed with Castleman's disease in Henan Provincial People's Hospital and the First Affiliated Hospital of Zhengzhou University from May 2010 to October 2019 were analyzed retrospectively. The clinical characteristics, laboratory examination and histopathological data were analyzed. Results: Among the 15 Castleman's disease patients, 12 were males and 3 females. The age of first visit was 12 (10, 15) years. The time from mass discovery to pathologic diagnosis was 9.0 (2.0, 13.0) months. The majority of patients were unicentric (13 cases), and the histopathological type was hyaline vascular (11 cases). Unicentric lesions were most common in the neck (11 cases), all 13 patients received complete surgical resection of the lesions, the follow-up time was 20.0 (13.5, 50.5) months, and the prognosis was good. Two cases were multicentric type, the pathological types were mixed variant, meeting the criteria of idiopathic Castleman's disease, the two children underwent partial surgical resection, one was treated with rituximab and prednisone and the other was treated with thalidomide and prednisone. The follow-up time was 32 months and 10 month, both of them had good prognosis. Conclusions: Most cases of Castleman's disease in children are diagnosed late, and the unicentric type is dominant. The most common pathological type is hyaline vascular, which is characterized by painless lymphadenopathy, while multicentric type has systemic symptoms and both of them have a good overall prognosis.
